Co-Authors
This is a "connection" page, showing publications co-authored by Gianpaolo Reboldi and Paolo Verdecchia.
Connection Strength
16.111
-
Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus. J Hypertens. 2020 06; 38(6):1190-1191.
Score: 0.885
-
Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes. N Engl J Med. 2019 10 24; 381(17):1691-1692.
Score: 0.849
-
Response by Verdecchia et al to Letter Regarding Article "Sudden Cardiac Death in Hypertensive Patients". Hypertension. 2019 Jul 01; HYPERTENSIONAHA11913441.
Score: 0.830
-
Sudden Cardiac Death in Hypertensive Patients. Hypertension. 2019 05; 73(5):1071-1078.
Score: 0.821
-
Keep Blood Pressure Low, but Not Too Much…. Circ Res. 2018 11 09; 123(11):1205-1207.
Score: 0.794
-
[What are the main novelties in the recent US and European guidelines for the management of hypertension?] G Ital Cardiol (Rome). 2018 Nov; 19(11):611-619.
Score: 0.793
-
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg? J Am Coll Cardiol. 2018 09 11; 72(11):1198-1200.
Score: 0.785
-
The 2018 ESC/ESH hypertension guidelines: Should nephrologists always stop at the lower boundary? J Nephrol. 2018 Oct; 31(5):621-626.
Score: 0.784
-
Hypertension and Atrial Fibrillation: Doubts and Certainties From Basic and Clinical Studies. Circ Res. 2018 01 19; 122(2):352-368.
Score: 0.751
-
The Tale of an Innocent: Intensive Treatment and the J-Curve in the SPRINT Trial (Systolic Blood Pressure Intervention Trial). Circulation. 2017 12 05; 136(23):2230-2232.
Score: 0.745
-
Intensive Blood Pressure Lowering and Regression of Left Ventricular Hypertrophy. Circulation. 2017 08 01; 136(5):451-453.
Score: 0.727
-
Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension. J Am Heart Assoc. 2017 May 24; 6(6).
Score: 0.718
-
How Low Should We Go With Blood Pressure? Circ Res. 2017 01 06; 120(1):27-29.
Score: 0.699
-
Does Malaria Cause Hypertension? Circ Res. 2016 06 24; 119(1):7-9.
Score: 0.674
-
[Blood pressure: the lower the better? Maybe yes]. G Ital Cardiol (Rome). 2016 May; 17(5):335-8.
Score: 0.667
-
[Arterial hypertension: an update]. G Ital Cardiol (Rome). 2010 May; 11(5 Suppl 3):74S-77S.
Score: 0.440
-
SARS-CoV-2 infection and ACE2 inhibition. J Hypertens. 2021 08 01; 39(8):1555-1558.
Score: 0.240
-
Ageing, ACE2 deficiency and bad outcome in COVID-19. Clin Chem Lab Med. 2021 06 14; 59(10):1607-1609.
Score: 0.238
-
SARS-CoV-2 vaccines: Lights and shadows. Eur J Intern Med. 2021 06; 88:1-8.
Score: 0.236
-
RAAS Inhibitors and Risk of Covid-19. N Engl J Med. 2020 Nov 12; 383(20):1990-1991.
Score: 0.228
-
Electrocardiographic features of patients with COVID-19 pneumonia. Eur J Intern Med. 2020 08; 78:101-106.
Score: 0.222
-
Non-inferiority Trial Design in Drug Development: A Primer for Cardiovascular Healthcare Professionals. Am J Cardiovasc Drugs. 2020 Jun; 20(3):229-238.
Score: 0.221
-
[ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]. G Ital Cardiol (Rome). 2020 May; 21(5):321-327.
Score: 0.220
-
Added predictive value of high uric acid for cardiovascular events in the Ambulatory Blood Pressure International Study. J Clin Hypertens (Greenwich). 2019 07; 21(7):966-974.
Score: 0.207
-
Tight Blood Pressure Control Saves Lives in Hypertensive Patients With Chronic Kidney Disease. Hypertension. 2019 06; 73(6):1172-1173.
Score: 0.206
-
Managing hypertension in 2018: which guideline to follow? Heart Asia. 2019; 11(1):e011127.
Score: 0.203
-
European and US guidelines for arterial hypertension: similarities and differences. Eur J Intern Med. 2019 05; 63:3-8.
Score: 0.202
-
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain. Expert Rev Clin Pharmacol. 2018 Nov; 11(11):1073-1084.
Score: 0.198
-
Gathering evidence on the prognostic role of central blood pressure in hypertension. Hypertens Res. 2018 11; 41(11):865-868.
Score: 0.197
-
Heart failure, pulse pressure and heart rate: Refining risk stratification. Int J Cardiol. 2018 11 15; 271:206-208.
Score: 0.194
-
Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease. J Hum Hypertens. 2018 09; 32(8-9):625-632.
Score: 0.193
-
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives. Expert Opin Drug Metab Toxicol. 2018 May; 14(5):533-541.
Score: 0.192
-
Left Ventricular Hypertrophy and Coronary Artery Calcifications: A Dangerous Duet? Am J Hypertens. 2018 02 09; 31(3):287-289.
Score: 0.189
-
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study. Europace. 2018 02 01; 20(2):253-262.
Score: 0.188
-
Glomerular hyperfiltration is a predictor of adverse cardiovascular outcomes. Kidney Int. 2018 01; 93(1):195-203.
Score: 0.183
-
Perioperative beta blockade: the debate continues. Lancet. 2009 Feb 21; 373(9664):627; author reply 628.
Score: 0.101
-
Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study. TH Open. 2019 Apr; 3(2):e157-e164.
Score: 0.052
-
Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis. Hypertension. 2016 Apr; 67(4):693-700.
Score: 0.041